WOLVERINE ASSET MANAGEMENT LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$3,159,000
+205.2%
14,567
+61.9%
0.03%
+107.7%
Q3 2019$1,035,000
-54.2%
9,000
-31.4%
0.01%
-55.2%
Q2 2019$2,260,000
-25.2%
13,120
-26.8%
0.03%
-29.3%
Q1 2019$3,021,000
-68.0%
17,931
-81.5%
0.04%
-63.7%
Q4 2018$9,445,000
+85763.6%
97,000
+96900.0%
0.11%
Q4 2016$11,000
-15.4%
1000.0%0.00%
Q3 2016$13,000
+44.4%
1000.0%0.00%
Q2 2016$9,0001000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders